Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation

Clinical Transplantation

Volumn 28, Issue 5, 2014, Pages 579-584

  Corey, Rebecca L ^a   Whitaker, Michael D ^b   Crowell, Michael D ^b   Keddis, Mira T ^b   Aqel, Bashar ^a,b   Balan, Vijayan ^a,b   Byrne, Thomas ^a,b   Carey, Elizabeth ^a,b   Douglas, David D ^a,b   Harrison, M Edwyn ^a,b   Vargas, Hugo E ^a,b   Rakela, Jorge ^a,b  

^a MAYO CLINIC HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic liver disease; Osteoporosis; Secondary hyperparathyroidism; Total 25 OH vitamin D; Vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; BILIRUBIN; CALCIUM; CREATININE; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BONE MINERAL; CALCIUM BLOOD LEVEL; CHRONIC LIVER DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; BONE DISEASES; END STAGE LIVER DISEASE; EPIDEMIOLOGY; FOLLOW UP; HOSPITAL ADMISSION; HYPERPARATHYROIDISM, SECONDARY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

BONE DISEASES; CALCIUM; CREATININE; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY; WAITING LISTS;

EID: 84899937474     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12351     Document Type: Article

References (21)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007: 357: 266.
2. Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 2011: 22: 216.
3. Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 2007: 13: 397.
4. Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am 2010: 39: 287.
5. Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012: 57: 897.
6. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011: 91: 115.
7. Abbott-Johnson W, Kerlin P, Clague A, Johnson H, Cuneo R. Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation. J Gastroenterol Hepatol 2011: 26: 1402.
8. Lim LY, Chalasani N. Vitamin D deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep 2012: 14: 67.
9. Venu M, Martin E, Saeian K, Gawrieh S. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver Transpl 2013: 19: 627.
10. Corey R, Whitaker M, Crowell MD et al. Vitamin D, A, and E deficiencies among patients with end stage liver disease (ESLD) awaiting liver transplantation (LT). Hepatology 2012: 56 (4 Suppl): 945A.
11. Corey R, Whitaker M, Crowell MD et al. Vitamin D deficiency, parathyroid hormone (PTH) levels, and bone disease among patients with end stage liver disease (ESLD) awaiting liver transplantation (LT). Hepatology 2012: 56 (4 Suppl): 941A.
12. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007: 5: 513.
13. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007: 45: 797.
14. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001: 33: 464.
15. Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996: 11: 417.
16. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986: 78: 748.
17. Reese PP, Bloom RD, Feldman HI et al. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int 2012: 32: 287.
18. Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 2010: 21: 1427.
19. Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011: 79: 1370.
20. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004: 19: 429.
21. Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 2009: 6: 660.